Yakov Kogan

Kadvax Technologies, Inc.

$3,816,502

Attributed

$6,597,573

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2017–25

$5M$3.8M$2.5M$1.3M$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,597,573 · 5

By mechanism

R44$5,093,561 · 2

R42$1,004,012 · 2

R41$500,000 · 1

Top collaborators

Most similar at Kadvax Technologies, Inc.

Same institution · by research overlap

Thomas Kosten$152,988

Others in their field

Other Emerging Leaders on “Dose”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
Susan Abushakra · Alzheon, Inc.$47,265,244
Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
Xinhua Li · Nano Terra, Inc.$35,520,438
Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028

Research focus

DoseCholesterolInflammationBinding ProteinsExcisionNeuroinflammationCellsMembrane MicrodomainsTlr4 GeneCell MembranePharmacologic SubstanceApolipoprotein A-IInflammatoryPharmaceutical PreparationsToxicologyCyclic GmpSafetyFormulationMacrophageRattusResponseOrganMeetingsProteins